
Curo Prime Pharmax Private Limited
Pharmaceutical company specializing in manufacturing and trading of medicines and supplements.
Pharmaceutical company specializing in manufacturing and trading of medicines and supplements.
Curo Prime Pharmax Private Limited (CPPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 2008 and has a history of 17 years and three months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.90 M.
The company currently has active open charges totaling ₹1.20 M. The company has closed loans amounting to ₹2.60 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Gupta, Sanjay Chamria, and Kushagar Chamaria serve as directors at the Company.
Jaipur, Rajasthan, India
+91-XXXXXXXXXX
U24232RJ2008PTC025682
025682
Private Limited Indian Non-Government Company
17 Jan 2008
30 Sep 2024
31 Mar 2024
Unlisted
Roc Jaipur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajay Gupta ![]() | Director | 06-May-2022 | Current |
Sanjay Chamria ![]() | Director | 03-Apr-2010 | Current |
Kushagar Chamaria ![]() | Director | 28-May-2022 | Current |
Curo Prime Pharmax Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.93% increase. The company also saw a substantial improvement in profitability, with a 372.3% increase in profit. The company's net worth moved up by a moderate rise of 8%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Curo Prime Pharmax had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sanjay Chamria is a mutual person
₹1.20 M
₹2.60 M
Date | Lender | Amount | Status |
---|---|---|---|
28 Dec 2023 | Others | ₹1.20 M | Open |
23 Jul 2021 | Hdfc Bank Limited | ₹0.70 M | Satisfied |
30 Aug 2019 | Others | ₹0.90 M | Satisfied |
06 Feb 2017 | Others | ₹1.00 M | Satisfied |
Unlock and access historical data on people associated with Curo Prime Pharmax, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curo Prime Pharmax, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curo Prime Pharmax's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 30 Aug 2019 via Charge ID 100287519 with Others was fully satisfied on 10 Oct 2024.
A charge registered on 23 Jul 2021 via Charge ID 100464696 with Hdfc Bank Limited was fully satisfied on 09 Oct 2024.
A charge registered on 06 Feb 2017 via Charge ID 100077494 with Others was fully satisfied on 09 Oct 2024.
Curo Prime Pharmax Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Curo Prime Pharmax Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
A charge with Others amounted to Rs. 1.20 M with Charge ID 100844491 was registered on 28 Dec 2023.
Curo Prime Pharmax Private Limited was incorporated on 17 Jan 2008.
The authorized share capital of Curo Prime Pharmax Private Limited is ₹ 3.00 M and paid-up capital is ₹ 2.90 M.
Currently 3 directors are associated with Curo Prime Pharmax Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Curo Prime Pharmax Private Limited is G-1 Plot No. 802 Rani Sati Nagar Bansi Path, Nirman Naga R India, Jaipur, Rajasthan, 302019.
The corporate identification number (CIN) of Curo Prime Pharmax Private Limited is U24232RJ2008PTC025682 and the company number is 025682 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Curo Prime Pharmax Private Limited has risen by 2.93%.
The financial reports for the fiscal year 2020 indicates that The net worth of Curo Prime Pharmax Private Limited has experienced an upsurge of 8.00%.
As per the financial statements for fiscal Year 2020, The total open charges for Curo Prime Pharmax Private Limited amount to ₹ 1.20 M.
The most recent Balance Sheet for Curo Prime Pharmax Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
CV
SG
SG
AK
KM
VM